About Adaptive Phage Therapeutics

Adaptive Phage Therapeutics provides therapeutic services intended to treat multi-drug resistant pathogenic bacteria. Its services are provided using clinical and therapeutic technology that matches phages to patient-specific bacterial infections, enabling medical researchers to develop drugs that can detect and eliminate multi-drug resistant bacteria.

Company Highlights
Year Founded

2016

icon-altStatus

Acquired

icon-altEmployees

36

Location (HQ)

USA

Since Last Funding

1 year 3 months

Monthly Website Visitors

3.2K

icon-altTotal Investment Amt

$100M

Last Funding Round

Series B

icon-altMoM Headcount Growth

-9.98%

icon-altYoY Headcount Growth

-42.79%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Pharmaceutical

Health Care

Biotechnology

Biotechnology Research

Therapeutics